AG

Anupam Gaur

Active Director Director DIN 00661383
DIN 00661383 First appointment Nov 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Anupam Gaur

Data last updated:

Anupam Gaur is a Director at Pushtinandaja Healthcare Private Limited (since 2024) and Director at Rejuvendus Clinical Research Private Limited (since 2006). The companies operate in Pharma.

DIN 00661383
Primary Designation Director
Industry Pharma
First Appointment 08 Nov 2006
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 May 20242024Active
Director08 Nov 20062006Active

Directorship timeline

Open interactive timeline →
Rejuvendus Clinical Research Private Limited
Pushtinandaja Healthcare Private Limited
Premium access

Shareholding and investment profile for Anupam Gaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anupam Gaur

Anupam Gaur currently holds 2 directorships: Pushtinandaja Healthcare Private Limited (Director, since 02 May 2024); Rejuvendus Clinical Research Private Limited (Director, since 08 Nov 2006).

Anupam Gaur was first appointed on 08 Nov 2006 as Director at Rejuvendus Clinical Research Private Limited. The most recent appointment on record is 02 May 2024 at Pushtinandaja Healthcare Private Limited.

The current boards of Anupam Gaur's companies include Neera Sharma (Pushtinandaja Healthcare Private Limited), Vikas Shri Prakash (Rejuvendus Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available